000 01527 a2200445 4500
005 20250514182511.0
264 0 _c20050202
008 200502s 0 0 eng d
022 _a0033-3158
024 7 _a10.1007/s00213-004-1830-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSlifstein, Mark
245 0 0 _aIn vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.
_h[electronic resource]
260 _bPsychopharmacology
_cSep 2004
300 _a274-86 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aBenzamides
_xmetabolism
650 0 4 _aBrain
_xmetabolism
650 0 4 _aFluorine Radioisotopes
650 0 4 _aIn Vitro Techniques
650 0 4 _aMale
650 0 4 _aOrgan Specificity
650 0 4 _aPapio
650 0 4 _aPositron-Emission Tomography
_xmethods
650 0 4 _aPyrrolidines
_xmetabolism
650 0 4 _aRadiopharmaceuticals
_xmetabolism
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aReceptors, Dopamine D2
_xmetabolism
700 1 _aHwang, Dah-Ren
700 1 _aHuang, Yiyun
700 1 _aGuo, Ningning
700 1 _aSudo, Yasuhiko
700 1 _aNarendran, Raj
700 1 _aTalbot, Peter
700 1 _aLaruelle, Marc
773 0 _tPsychopharmacology
_gvol. 175
_gno. 3
_gp. 274-86
856 4 0 _uhttps://doi.org/10.1007/s00213-004-1830-x
_zAvailable from publisher's website
999 _c14742841
_d14742841